Rare diseases
Investigational molecules
Locations
Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis
GermanyStudy on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis
GermanyStudy of Durbactagene Autoleucel and Drug Combination for Adults with Relapsed and Refractory Multiple Myeloma
GermanyStudy on the Safety and Tolerability of ST-920 Gene Therapy for Patients with Fabry Disease
GermanyStudy on the Safety of Tirbanibulin and Diclofenac Sodium for Adults with Actinic Keratosis on the Face or Scalp
GermanyStudy of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
GermanyStudy on the Effectiveness and Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a 36-Week Refill System
GermanyStudy of Vorasidenib for Patients with Residual or Recurrent Grade 2 Glioma with IDH1 or IDH2 Mutation
GermanyStudy on Bimekizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis
GermanyStudy Comparing Teclistamab with Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
GermanyStudy Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant
GermanyStudy on Regorafenib and Nivolumab for Patients with Advanced Gastro-Oesophageal Cancer
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
